Editorial

Show 31-40 of 100 results

01 Feb 2022 : Editorial

Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2

Dinah V. Parums,

DOI: 10.12659/MSM.936199

01 Jan 2022 : Editorial

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients

Dinah V. Parums,

DOI: 10.12659/MSM.935952

01 Dec 2021 : Editorial

Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.935624

01 Nov 2021 : Editorial

Editorial: What Can be Learned from National and International Vaccine Adverse Event Reporting Systems During the COVID-19 Pandemic?

Dinah V. Parums,

DOI: 10.12659/MSM.935299

25 Oct 2021 : Editorial

Editorial: The 2021 European Society of Cardiology (ESC) Guidelines on the Real-World Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)

Dinah V. Parums,

DOI: 10.12659/MSM.935172

18 Oct 2021 : Editorial

Editorial: Global Initiatives Support the Use and Regulation of Digital Health Technology During the COVID-19 Pandemic

Dinah V. Parums,

DOI: 10.12659/MSM.935123

11 Oct 2021 : Editorial

Editorial: Multisystem Inflammatory Syndrome in Adults (MIS-A) and the Spectrum of COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.935005

04 Oct 2021 : Editorial

Editorial: A Decline in Influenza During the COVID-19 Pandemic and the Emergence of Potential Epidemic and Pandemic Influenza Viruses

Dinah V. Parums,

DOI: 10.12659/MSM.934949

27 Sep 2021 : Editorial

Editorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic Monoclonal Antibody for Advanced Non-Small Cell Lung Cancer (NSCLC)

Dinah V. Parums,

DOI: 10.12659/MSM.934854

20 Sep 2021 : Editorial

Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.934766